Sung Ji Nam
Stock Analyst at BTIG
(3.23)
# 1,152
Out of 4,412 analysts
39
Total ratings
48.78%
Success rate
1.9%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DMTK DermTech | Downgrades: Neutral | n/a | $0.60 | - | 2 | Apr 19, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Sector Outperform | $15 → $8 | $1.47 | +444.22% | 2 | Apr 18, 2024 | |
| BNGO Bionano Genomics | Maintains: Sector Outperform | $7 → $6 | $0.79 | +663.26% | 4 | Mar 7, 2024 | |
| CSTL Castle Biosciences | Maintains: Sector Outperform | $33 → $37 | $20.34 | +81.91% | 3 | Mar 1, 2024 | |
| TWST Twist Bioscience | Maintains: Sector Outperform | $30 → $43 | $31.54 | +36.33% | 2 | Feb 5, 2024 | |
| ILMN Illumina | Upgrades: Sector Outperform | n/a | $122.28 | - | 4 | Dec 19, 2023 | |
| OLK Olink Holding AB (publ) | Downgrades: Sector Perform | n/a | $22.84 | - | 3 | Oct 18, 2023 | |
| TKNO Alpha Teknova | Assumes: Buy | $6 | $1.73 | +246.82% | 2 | Jun 29, 2023 | |
| CDNA CareDx | Downgrades: Neutral | n/a | $7.56 | - | 2 | May 11, 2023 | |
| GH Guardant Health | Initiates: Sector Outperform | $36 | $17.35 | +107.49% | 2 | Jan 5, 2023 | |
| VCYT Veracyte | Initiates: Sector Outperform | $33 | $19.31 | +70.90% | 2 | Jan 5, 2023 | |
| ADPT Adaptive Biotechnologies | Initiates: Sector Outperform | $15 | $2.60 | +476.92% | 1 | Jan 5, 2023 | |
| TMO Thermo Fisher | Maintains: Buy | $718 | $573.60 | +25.17% | 8 | Feb 2, 2022 | |
| FLGT Fulgent Genetics | Downgrades: Neutral | n/a | $20.10 | - | 2 | Nov 24, 2020 |
DermTech
Apr 19, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.60
Upside: -
Pacific Biosciences of California
Apr 18, 2024
Maintains: Sector Outperform
Price Target: $15 → $8
Current: $1.47
Upside: +444.22%
Bionano Genomics
Mar 7, 2024
Maintains: Sector Outperform
Price Target: $7 → $6
Current: $0.79
Upside: +663.26%
Castle Biosciences
Mar 1, 2024
Maintains: Sector Outperform
Price Target: $33 → $37
Current: $20.34
Upside: +81.91%
Twist Bioscience
Feb 5, 2024
Maintains: Sector Outperform
Price Target: $30 → $43
Current: $31.54
Upside: +36.33%
Illumina
Dec 19, 2023
Upgrades: Sector Outperform
Price Target: n/a
Current: $122.28
Upside: -
Olink Holding AB (publ)
Oct 18, 2023
Downgrades: Sector Perform
Price Target: n/a
Current: $22.84
Upside: -
Alpha Teknova
Jun 29, 2023
Assumes: Buy
Price Target: $6
Current: $1.73
Upside: +246.82%
CareDx
May 11, 2023
Downgrades: Neutral
Price Target: n/a
Current: $7.56
Upside: -
Guardant Health
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $36
Current: $17.35
Upside: +107.49%
Veracyte
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $33
Current: $19.31
Upside: +70.90%
Adaptive Biotechnologies
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $15
Current: $2.60
Upside: +476.92%
Thermo Fisher
Feb 2, 2022
Maintains: Buy
Price Target: $718
Current: $573.60
Upside: +25.17%
Fulgent Genetics
Nov 24, 2020
Downgrades: Neutral
Price Target: n/a
Current: $20.10
Upside: -